Global Preventive Vaccines Market Growth 2025-2031

December 2025 | 93 pages | ID: G5BAAB1F7455EN
LP Information

Abstracts

The global Preventive Vaccines market size is predicted to grow from US$ 67920 million in 2025 to US$ 113290 million in 2031; it is expected to grow at a CAGR of 8.9% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.

United States market for Preventive Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Preventive Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Preventive Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Preventive Vaccines players cover Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Preventive Vaccines Industry Forecast” looks at past sales and reviews total world Preventive Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Preventive Vaccines sales for 2025 through 2031. With Preventive Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preventive Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Preventive Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Preventive Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preventive Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preventive Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preventive Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Preventive Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Intramuscular Injection
• Nasal Spray
• Intradermal Shot

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Sanofi
• AstraZeneca
• CSL Ltd
• Abbott
• GlaxoSmithKline
• Serum Institute of India

Key Questions Addressed in this Report

What is the 10-year outlook for the global Preventive Vaccines market?

What factors are driving Preventive Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Preventive Vaccines market opportunities vary by end market size?

How does Preventive Vaccines break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Preventive Vaccines Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Preventive Vaccines by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Preventive Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Preventive Vaccines Segment by Type
  2.2.1 Intramuscular Injection
  2.2.2 Nasal Spray
  2.2.3 Intradermal Shot
2.3 Preventive Vaccines Sales by Type
  2.3.1 Global Preventive Vaccines Sales Market Share by Type (2020-2025)
  2.3.2 Global Preventive Vaccines Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Preventive Vaccines Sale Price by Type (2020-2025)
2.4 Preventive Vaccines Segment by Application
  2.4.1 Hospital
  2.4.2 Clinic
  2.4.3 Other
2.5 Preventive Vaccines Sales by Application
  2.5.1 Global Preventive Vaccines Sale Market Share by Application (2020-2025)
  2.5.2 Global Preventive Vaccines Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Preventive Vaccines Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Preventive Vaccines Breakdown Data by Company
  3.1.1 Global Preventive Vaccines Annual Sales by Company (2020-2025)
  3.1.2 Global Preventive Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Preventive Vaccines Annual Revenue by Company (2020-2025)
  3.2.1 Global Preventive Vaccines Revenue by Company (2020-2025)
  3.2.2 Global Preventive Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Preventive Vaccines Sale Price by Company
3.4 Key Manufacturers Preventive Vaccines Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Preventive Vaccines Product Location Distribution
  3.4.2 Players Preventive Vaccines Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR PREVENTIVE VACCINES BY GEOGRAPHIC REGION

4.1 World Historic Preventive Vaccines Market Size by Geographic Region (2020-2025)
  4.1.1 Global Preventive Vaccines Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Preventive Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Preventive Vaccines Market Size by Country/Region (2020-2025)
  4.2.1 Global Preventive Vaccines Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Preventive Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Preventive Vaccines Sales Growth
4.4 APAC Preventive Vaccines Sales Growth
4.5 Europe Preventive Vaccines Sales Growth
4.6 Middle East & Africa Preventive Vaccines Sales Growth

5 AMERICAS

5.1 Americas Preventive Vaccines Sales by Country
  5.1.1 Americas Preventive Vaccines Sales by Country (2020-2025)
  5.1.2 Americas Preventive Vaccines Revenue by Country (2020-2025)
5.2 Americas Preventive Vaccines Sales by Type (2020-2025)
5.3 Americas Preventive Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Preventive Vaccines Sales by Region
  6.1.1 APAC Preventive Vaccines Sales by Region (2020-2025)
  6.1.2 APAC Preventive Vaccines Revenue by Region (2020-2025)
6.2 APAC Preventive Vaccines Sales by Type (2020-2025)
6.3 APAC Preventive Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Preventive Vaccines by Country
  7.1.1 Europe Preventive Vaccines Sales by Country (2020-2025)
  7.1.2 Europe Preventive Vaccines Revenue by Country (2020-2025)
7.2 Europe Preventive Vaccines Sales by Type (2020-2025)
7.3 Europe Preventive Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Preventive Vaccines by Country
  8.1.1 Middle East & Africa Preventive Vaccines Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Preventive Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Preventive Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Preventive Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Preventive Vaccines
10.3 Manufacturing Process Analysis of Preventive Vaccines
10.4 Industry Chain Structure of Preventive Vaccines

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Preventive Vaccines Distributors
11.3 Preventive Vaccines Customer

12 WORLD FORECAST REVIEW FOR PREVENTIVE VACCINES BY GEOGRAPHIC REGION

12.1 Global Preventive Vaccines Market Size Forecast by Region
  12.1.1 Global Preventive Vaccines Forecast by Region (2026-2031)
  12.1.2 Global Preventive Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Preventive Vaccines Forecast by Type (2026-2031)
12.7 Global Preventive Vaccines Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Preventive Vaccines Product Portfolios and Specifications
  13.1.3 Sanofi Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 AstraZeneca
  13.2.1 AstraZeneca Company Information
  13.2.2 AstraZeneca Preventive Vaccines Product Portfolios and Specifications
  13.2.3 AstraZeneca Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 AstraZeneca Main Business Overview
  13.2.5 AstraZeneca Latest Developments
13.3 CSL Ltd
  13.3.1 CSL Ltd Company Information
  13.3.2 CSL Ltd Preventive Vaccines Product Portfolios and Specifications
  13.3.3 CSL Ltd Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 CSL Ltd Main Business Overview
  13.3.5 CSL Ltd Latest Developments
13.4 Abbott
  13.4.1 Abbott Company Information
  13.4.2 Abbott Preventive Vaccines Product Portfolios and Specifications
  13.4.3 Abbott Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Abbott Main Business Overview
  13.4.5 Abbott Latest Developments
13.5 GlaxoSmithKline
  13.5.1 GlaxoSmithKline Company Information
  13.5.2 GlaxoSmithKline Preventive Vaccines Product Portfolios and Specifications
  13.5.3 GlaxoSmithKline Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 GlaxoSmithKline Main Business Overview
  13.5.5 GlaxoSmithKline Latest Developments
13.6 Serum Institute of India
  13.6.1 Serum Institute of India Company Information
  13.6.2 Serum Institute of India Preventive Vaccines Product Portfolios and Specifications
  13.6.3 Serum Institute of India Preventive Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Serum Institute of India Main Business Overview
  13.6.5 Serum Institute of India Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Preventive Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Preventive Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Intramuscular Injection
Table 4. Major Players of Nasal Spray
Table 5. Major Players of Intradermal Shot
Table 6. Global Preventive Vaccines Sales by Type (2020-2025) & (K Doses)
Table 7. Global Preventive Vaccines Sales Market Share by Type (2020-2025)
Table 8. Global Preventive Vaccines Revenue by Type (2020-2025) & ($ million)
Table 9. Global Preventive Vaccines Revenue Market Share by Type (2020-2025)
Table 10. Global Preventive Vaccines Sale Price by Type (2020-2025) & (USD/Doses)
Table 11. Global Preventive Vaccines Sale by Application (2020-2025) & (K Doses)
Table 12. Global Preventive Vaccines Sale Market Share by Application (2020-2025)
Table 13. Global Preventive Vaccines Revenue by Application (2020-2025) & ($ million)
Table 14. Global Preventive Vaccines Revenue Market Share by Application (2020-2025)
Table 15. Global Preventive Vaccines Sale Price by Application (2020-2025) & (USD/Doses)
Table 16. Global Preventive Vaccines Sales by Company (2020-2025) & (K Doses)
Table 17. Global Preventive Vaccines Sales Market Share by Company (2020-2025)
Table 18. Global Preventive Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Preventive Vaccines Revenue Market Share by Company (2020-2025)
Table 20. Global Preventive Vaccines Sale Price by Company (2020-2025) & (USD/Doses)
Table 21. Key Manufacturers Preventive Vaccines Producing Area Distribution and Sales Area
Table 22. Players Preventive Vaccines Products Offered
Table 23. Preventive Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Preventive Vaccines Sales by Geographic Region (2020-2025) & (K Doses)
Table 27. Global Preventive Vaccines Sales Market Share Geographic Region (2020-2025)
Table 28. Global Preventive Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Preventive Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Preventive Vaccines Sales by Country/Region (2020-2025) & (K Doses)
Table 31. Global Preventive Vaccines Sales Market Share by Country/Region (2020-2025)
Table 32. Global Preventive Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Preventive Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Preventive Vaccines Sales by Country (2020-2025) & (K Doses)
Table 35. Americas Preventive Vaccines Sales Market Share by Country (2020-2025)
Table 36. Americas Preventive Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Preventive Vaccines Sales by Type (2020-2025) & (K Doses)
Table 38. Americas Preventive Vaccines Sales by Application (2020-2025) & (K Doses)
Table 39. APAC Preventive Vaccines Sales by Region (2020-2025) & (K Doses)
Table 40. APAC Preventive Vaccines Sales Market Share by Region (2020-2025)
Table 41. APAC Preventive Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Preventive Vaccines Sales by Type (2020-2025) & (K Doses)
Table 43. APAC Preventive Vaccines Sales by Application (2020-2025) & (K Doses)
Table 44. Europe Preventive Vaccines Sales by Country (2020-2025) & (K Doses)
Table 45. Europe Preventive Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Preventive Vaccines Sales by Type (2020-2025) & (K Doses)
Table 47. Europe Preventive Vaccines Sales by Application (2020-2025) & (K Doses)
Table 48. Middle East & Africa Preventive Vaccines Sales by Country (2020-2025) & (K Doses)
Table 49. Middle East & Africa Preventive Vaccines Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Preventive Vaccines Sales by Type (2020-2025) & (K Doses)
Table 51. Middle East & Africa Preventive Vaccines Sales by Application (2020-2025) & (K Doses)
Table 52. Key Market Drivers & Growth Opportunities of Preventive Vaccines
Table 53. Key Market Challenges & Risks of Preventive Vaccines
Table 54. Key Industry Trends of Preventive Vaccines
Table 55. Preventive Vaccines Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Preventive Vaccines Distributors List
Table 58. Preventive Vaccines Customer List
Table 59. Global Preventive Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 60. Global Preventive Vaccines Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Preventive Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 62. Americas Preventive Vaccines Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Preventive Vaccines Sales Forecast by Region (2026-2031) & (K Doses)
Table 64. APAC Preventive Vaccines Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Preventive Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 66. Europe Preventive Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Preventive Vaccines Sales Forecast by Country (2026-2031) & (K Doses)
Table 68. Middle East & Africa Preventive Vaccines Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Preventive Vaccines Sales Forecast by Type (2026-2031) & (K Doses)
Table 70. Global Preventive Vaccines Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Preventive Vaccines Sales Forecast by Application (2026-2031) & (K Doses)
Table 72. Global Preventive Vaccines Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Sanofi Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 74. Sanofi Preventive Vaccines Product Portfolios and Specifications
Table 75. Sanofi Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 76. Sanofi Main Business
Table 77. Sanofi Latest Developments
Table 78. AstraZeneca Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Preventive Vaccines Product Portfolios and Specifications
Table 80. AstraZeneca Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. CSL Ltd Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Ltd Preventive Vaccines Product Portfolios and Specifications
Table 85. CSL Ltd Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 86. CSL Ltd Main Business
Table 87. CSL Ltd Latest Developments
Table 88. Abbott Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Abbott Preventive Vaccines Product Portfolios and Specifications
Table 90. Abbott Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 91. Abbott Main Business
Table 92. Abbott Latest Developments
Table 93. GlaxoSmithKline Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. GlaxoSmithKline Preventive Vaccines Product Portfolios and Specifications
Table 95. GlaxoSmithKline Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 96. GlaxoSmithKline Main Business
Table 97. GlaxoSmithKline Latest Developments
Table 98. Serum Institute of India Basic Information, Preventive Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Serum Institute of India Preventive Vaccines Product Portfolios and Specifications
Table 100. Serum Institute of India Preventive Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2025)
Table 101. Serum Institute of India Main Business
Table 102. Serum Institute of India Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Preventive Vaccines
Figure 2. Preventive Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Preventive Vaccines Sales Growth Rate 2020-2031 (K Doses)
Figure 7. Global Preventive Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Preventive Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Preventive Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Preventive Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Intramuscular Injection
Figure 12. Product Picture of Nasal Spray
Figure 13. Product Picture of Intradermal Shot
Figure 14. Global Preventive Vaccines Sales Market Share by Type in 2025
Figure 15. Global Preventive Vaccines Revenue Market Share by Type (2020-2025)
Figure 16. Preventive Vaccines Consumed in Hospital
Figure 17. Global Preventive Vaccines Market: Hospital (2020-2025) & (K Doses)
Figure 18. Preventive Vaccines Consumed in Clinic
Figure 19. Global Preventive Vaccines Market: Clinic (2020-2025) & (K Doses)
Figure 20. Preventive Vaccines Consumed in Other
Figure 21. Global Preventive Vaccines Market: Other (2020-2025) & (K Doses)
Figure 22. Global Preventive Vaccines Sale Market Share by Application (2024)
Figure 23. Global Preventive Vaccines Revenue Market Share by Application in 2025
Figure 24. Preventive Vaccines Sales by Company in 2025 (K Doses)
Figure 25. Global Preventive Vaccines Sales Market Share by Company in 2025
Figure 26. Preventive Vaccines Revenue by Company in 2025 ($ millions)
Figure 27. Global Preventive Vaccines Revenue Market Share by Company in 2025
Figure 28. Global Preventive Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 29. Global Preventive Vaccines Revenue Market Share by Geographic Region in 2025
Figure 30. Americas Preventive Vaccines Sales 2020-2025 (K Doses)
Figure 31. Americas Preventive Vaccines Revenue 2020-2025 ($ millions)
Figure 32. APAC Preventive Vaccines Sales 2020-2025 (K Doses)
Figure 33. APAC Preventive Vaccines Revenue 2020-2025 ($ millions)
Figure 34. Europe Preventive Vaccines Sales 2020-2025 (K Doses)
Figure 35. Europe Preventive Vaccines Revenue 2020-2025 ($ millions)
Figure 36. Middle East & Africa Preventive Vaccines Sales 2020-2025 (K Doses)
Figure 37. Middle East & Africa Preventive Vaccines Revenue 2020-2025 ($ millions)
Figure 38. Americas Preventive Vaccines Sales Market Share by Country in 2025
Figure 39. Americas Preventive Vaccines Revenue Market Share by Country (2020-2025)
Figure 40. Americas Preventive Vaccines Sales Market Share by Type (2020-2025)
Figure 41. Americas Preventive Vaccines Sales Market Share by Application (2020-2025)
Figure 42. United States Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 43. Canada Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 44. Mexico Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 45. Brazil Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 46. APAC Preventive Vaccines Sales Market Share by Region in 2025
Figure 47. APAC Preventive Vaccines Revenue Market Share by Region (2020-2025)
Figure 48. APAC Preventive Vaccines Sales Market Share by Type (2020-2025)
Figure 49. APAC Preventive Vaccines Sales Market Share by Application (2020-2025)
Figure 50. China Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 51. Japan Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 52. South Korea Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast Asia Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 54. India Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 55. Australia Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. China Taiwan Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Europe Preventive Vaccines Sales Market Share by Country in 2025
Figure 58. Europe Preventive Vaccines Revenue Market Share by Country (2020-2025)
Figure 59. Europe Preventive Vaccines Sales Market Share by Type (2020-2025)
Figure 60. Europe Preventive Vaccines Sales Market Share by Application (2020-2025)
Figure 61. Germany Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 62. France Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 63. UK Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Italy Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. Russia Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & Africa Preventive Vaccines Sales Market Share by Country (2020-2025)
Figure 67. Middle East & Africa Preventive Vaccines Sales Market Share by Type (2020-2025)
Figure 68. Middle East & Africa Preventive Vaccines Sales Market Share by Application (2020-2025)
Figure 69. Egypt Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. South Africa Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 71. Israel Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 72. Turkey Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC Countries Preventive Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Preventive Vaccines in 2025
Figure 75. Manufacturing Process Analysis of Preventive Vaccines
Figure 76. Industry Chain Structure of Preventive Vaccines
Figure 77. Channels of Distribution
Figure 78. Global Preventive Vaccines Sales Market Forecast by Region (2026-2031)
Figure 79. Global Preventive Vaccines Revenue Market Share Forecast by Region (2026-2031)
Figure 80. Global Preventive Vaccines Sales Market Share Forecast by Type (2026-2031)
Figure 81. Global Preventive Vaccines Revenue Market Share Forecast by Type (2026-2031)
Figure 82. Global Preventive Vaccines Sales Market Share Forecast by Application (2026-2031)
Figure 83. Global Preventive Vaccines Revenue Market Share Forecast by Application (2026-2031)